












Ritu Lal
Founder at GEn1E Lifesciences
Ritu Lal was the founder of GEn1E Lifesciences which went through YC in S19. GEn1E Lifesciences is a Clinical-stage, multi-target company with a unique AI platform. We develop novel, next-generation, immunomodulatory therapies for rare & inflammatory diseases with no effective treatments.
Follow Ritu
Previously at

Mallinckrodt Pharmaceuticals
Mallinckrodt, Autoimmune and Rare Diseases Unit
Mallinckrodt Inc., Autoimmune and Rare Diseases Unit
Advisor to Drug, Device and Diagnostic Companies
XenoPort, Inc.

Roche
Roche Palo Alto
Abbott Laboratories

Abbott
Alumnus of

Stanford University

University Of Maryland

University of Arizona
University of Mumbai